Jump to navigation

The University of Arizona Wordmark Line Logo White
UA Profiles | Home
  • Phonebook
  • Edit My Profile
  • Feedback

Profiles search form

Alejandro Vazquez

  • Assistant Clinical Professor
Contact
  • (602) 827-2910
  • UA Coll of Med-Phx-Student Bld, Rm. 3266
  • Tucson, AZ 85724
  • vazqua@arizona.edu
  • Bio
  • Interests
  • Courses
  • Scholarly Contributions

Biography

Alejandro Vazquez, PharmD is an Assistant Professor with the Department of Pharmacy Practice and Science.  He completed a residency in Ambulatory Care and academia with The University of Florida College of Pharmacy and Gulf Coast Area Health Education Centers.  He also received a teaching certificate from the same program.  Previously, he practiced chronic disease management in homeless and indigent patients at Turning Points Clinic in Bradenton, FL.  He currently practices Ambulatory Care with Banner Health Pharmacy Service.

His areas of interest include chronic disease management, focusing on tobacco cessation, asthma and COPD, diabetes, hypertension, and dyslipidemia.

Degrees

  • Pharm.D. Pharmacy
    • University of Florida, Gainesville, Florida, United States
  • B.S. Chemistry
    • University of Florida, Gainesville, Florida, United States

Work Experience

  • Banner University Medical Center (2020 - Ongoing)
  • University of Arizona College of Pharmacy (2020 - Ongoing)
  • LECOM School of Pharmacy (2010 - 2020)
  • Suwannee River Area Health Education Centers (2009 - 2010)
  • University of Florida - Working Professional PharmD Program (2009 - 2010)
  • North Florida Regional Medical Center (2007)
  • Westlab Pharmacy (2006 - 2009)
  • Walgreens Pharmacy (2005 - 2006)
  • Miami Dade College (2001 - 2002)

Licensure & Certification

  • RPh, Florida State Board of Pharmacy (2009)
  • RPh, Arizona State Board of Pharmacy (2020)

Related Links

Share Profile

Interests

Research

Ambulatory CareIndigent Patient PopulationsPatient Self-EfficacyPharmacy Interventions in Chronic Disease Management

Teaching

DiabetesHypertensionDyslipidemiaAsthmaCOPDTobacco CessationDrug InformationClinical Skills

Courses

2024-25 Courses

  • Advanced Patient Care
    PHPR 811 (Spring 2025)
  • Independent Study
    PHPR 899 (Spring 2025)
  • Pharmacotherapeutics V
    PHPR 860E (Spring 2025)
  • Independent Study
    PHPR 899 (Fall 2024)
  • Patient Assessmnt+Diagn
    PHPR 816A (Fall 2024)

2023-24 Courses

  • Advanced Patient Care
    PHPR 811 (Spring 2024)
  • Case Stds/Pharmacology
    PCOL 821 (Spring 2024)
  • Pharmacotherapeutics V
    PHPR 860E (Spring 2024)
  • Comm Skills and Human Behavior
    PHPR 804 (Fall 2023)
  • Patient Assessmnt+Diagn
    PHPR 816A (Fall 2023)
  • Pharmacotherapeutics II
    PHPR 860B (Fall 2023)

2022-23 Courses

  • Pharmacotherapeutics V
    PHPR 860E (Spring 2023)
  • Patient Assessmnt+Diagn
    PHPR 816A (Fall 2022)

2021-22 Courses

  • Pharmacotherapeutics V
    PHPR 860E (Spring 2022)
  • Patient Assessmnt+Diagn
    PHPR 816A (Fall 2021)

2020-21 Courses

  • Pharm Product Prep & Calc
    PHPR 810 (Spring 2021)

Related Links

UA Course Catalog

Scholarly Contributions

Journals/Publications

  • Zerr, B., Vazquez, A., & Erstad, B. L. (2023).

    Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors

    . American Journal of Health-System Pharmacy, 80(15), 967-973. doi:10.1093/ajhp/zxad089
  • Tromp, K. M., Campbell, M. W., Vazquez, A., Tromp, K. M., Campbell, M. W., & Vazquez, A. (2015). Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.. Clinical therapeutics, 37(5), 928-34. doi:10.1016/j.clinthera.2015.03.025
    More info
    The goal of this article was to review the key clinical trials that resulted in the recent recommendation from the Advisory Committee on Immunization Practices (ACIP) to vaccinate all adults aged ≥65 years with the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13) in addition to the previously recommended 23-valent pneumococcal polysaccharide vaccine (PPSV23)..Pertinent articles were identified through searches of EMBASE and MEDLINE by using the terms pneumococcal polysaccharide conjugate vaccine, pneumococcal vaccine, and PCV13. Searches were limited to articles published between January 1, 2013, and January 31, 2015, and were limited to clinical trials. Resources from the Centers for Disease Control and Prevention's ACIP recommendations and cited references were also reviewed..Recent clinical trials have focused on the order of administration of PPSV23 and PCV13, comparisons in immunogenicity of PPSV23 and PCV13, and efficacy of PCV13 in adults aged ≥65 years. Immunogenicity trials have shown that PCV13 elicits an equal or greater immune response than PPSV23 for most of the serotypes that both vaccines share. The evidence suggests that PCV13 should be administered before PPSV23 when possible. Most recently, clinical data demonstrated the efficacy of PCV13 in adults aged ≥65 years..Recent randomized clinical trials and disease trends have prompted the ACIP to recommend that all adults aged ≥65 years receive a single dose of PCV13. This is in addition to the previous recommended single dose of PPSV23 in the same population. The ACIP and the Centers for Disease Control and Prevention plan to monitor disease trends and clinical data to determine if this recommendation will need to be changed in the future.

Presentations

  • Vazquez, A. (2022, Fall). Implementing a Tobacco Cessation Collaborative Practice Agreement. . AzPA.

Poster Presentations

  • Vazquez, A. (2024, October). Overcoming Influenza Vaccine Hesitancy Among Generations Through Creative Social Media Videos. ACCP Annual meeting.
  • Alvarez, N. A., Vazquez, A., Henry, N., & Boske, B. (2022, May). What is the correlation between receipt of a COVID-19 vaccine and receipt of an annual flu shot?
    . National Association of Boards of Pharmacy Annual Meeting. Phoenix, AZ: Vazquez A, Henry N, Boske B, Alvarez NA..
  • Vazquez, A. (2022, Fall 2022). Review of flu and pneumococcal vaccine data in diabetic patients to evaluate quality issues.. University of Arizona.
  • Vazquez, A. (2022, Spring). Identifying Barriers to Vaccination: What is the Correlation Between Receipt of Covid-19 Vaccine and Receipt of an Annual Flu Shot? . AzPA Fall Conference.

Profiles With Related Publications

  • Brian L Erstad
  • Beth Zerr
  • Nicole Henry
  • Nancy Ann Alvarez

 Edit my profile

UA Profiles | Home

University Information Security and Privacy

© 2025 The Arizona Board of Regents on behalf of The University of Arizona.